Roots Analysis has announced the addition of “Quantum Computing in Drug Discovery Services Market, 2023-2035” report to its list of offerings.
Key Market Insights
- Presently, over 45 players around the globe claim to offer quantum computing services across different steps of drug discovery
- Leveraging their expertise, 86% stakeholders offer such services across target discovery / identification, primarily focusing on oncological disorders
- In pursuit of gaining a competitive edge, manufacturers claim to be steadily expanding their existing capabilities in order to enhance their service portfolio related to quantum computing
- Grants worth over USD 70 million have been awarded to various organizations that have actively undertaken R&D efforts to evaluate the potential of quantum computing in drug discovery
- A considerable increase in the partnership activity has been witnessed in the past few years; close to 50% of the collaborations were inked by firms based in the same region
- More than 30 players, worldwide, claim to offer hardware-as-a-service for quantum computing in drug discovery, and have developed the required expertise in different types of computational approaches
- Majority of the quantum computing hardware providers, headquartered in North America, were established before the year 2000; in fact, ~50% of the overall market landscape is catered to by large companies.
- The rise in the adoption of quantum computing in the biopharmaceutical industry is anticipated to create profitable business opportunities for both software and hardware providers
- Based on the pioneer-migrator-settler map, we have classified the software providers into different categories; a selection of pioneers is expected to provide valuable offerings to lead the market in the longer term
- We expect the market to grow at an annualized rate of 14% in the coming decade; the opportunity is likely to be well distributed across types of drug discovery services, therapeutic areas and key geographical regions
Table of Contents
- PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
- EXECUTIVE SUMMARY
- INTRODUCTION
3.1. Overview of Quantum Computing in Drug Discovery
3.2. Drug Discovery and Development Timeline
3.3. Historical Evolution of Computational Drug Discovery Approaches
3.4. Classification of Quantum Computing Approaches
3.5. Applications of Quantum Computing in Drug Discovery Process
3.6. Advantages of Quantum Computing in Drug Discovery
3.7. Challenges Associated with Quantum Computing in Drug Discovery
3.8. Future Perspectives
- MARKET LANDSCAPE: SOFTWARE PROVIDERS
4.1. Quantum Computing Software Providers: Overall Market Landscape
- COMPANY COMPETITIVENESS ANALYSIS
5.1. Methodology and Key Parameters
5.2 Scoring Criteria
5.3. Company Competitiveness Analysis: Players based in North America (Peer Group I)
5.4. Company Competitiveness Analysis: Players based in Europe (Peer Group II)
5.5. Company Competitiveness Analysis: Players based in Asia-Pacific and Rest of the World (Peer Group III)
- COMPANY PROFILES: SOFTWARE PROVIDERS
6.1. Accenture
6.1.1. Company Overview
6.1.2. Financial Information
6.1.3. Service Portfolio
6.1.4. Recent Developments and Future Outlook
6.2. Atos
6.3. Fujitsu
6.4. Huawei
6.5. Microsoft
6.6. Xanadu
6.7. XtalPi
- MARKET LANDSCAPE: HARDWARE PROVIDERS
7.1. Quantum Computing Hardware Providers: Overall Market Landscape
- COMPANY PROFILES: HARDWARE PROVIDERS
8.1. Amazon Web Services
8.1.1. Company Overview
8.1.2. Financial Information
8.1.3. Service Portfolio
8.1.4. Recent Developments and Future Outlook
8.2. IBM
8.3. Microsoft
- ACADEMIC GRANTS ANALYSIS
9.1. Analysis Methodology
9.2. Key Parameters
9.3. Analysis by Year of Grant
9.4. Analysis by Amount Awarded
9.5. Analysis by Support Period
9.6. Analysis by Study Section
9.7. Word Cloud Analysis: Emerging Focus Areas
9.8. Analysis by Administering Institute Center
9.9. Analysis by Type of Grant
9.10. Analysis by Activity Code
9.11. Analysis by Purpose of Grant
9.12. Analysis by Administering Institute Center and Support Period
9.13. Prominent Program Officers: Analysis by Number of Grants
9.14. Analysis by Location of Recipient Organizations
9.15. Analysis by Type of Organization
9.16. Popular Recipient Organizations: Analysis by Number of Grants
9.17. Popular Recipient Organizations: Analysis by Amount Awarded
- PARTNERSHIPS AND COLLABORATIONS
10.1. Partnership Models
10.2. Quantum Computing in Drug Discovery, Drug Manufacturing and Other Services: Partnerships and Collaborations
10.3. Analysis by Year of Partnership
10.4. Analysis by Type of Partnership
10.5. Analysis by Year and Type of Partnership
10.6. Most Active Players: Analysis by Number of Partnerships
10.7. Word Cloud Analysis: Key Focus Areas
10.8. Analysis by Type of Continent
10.9. Analysis by Company Size and Type of Partnership
10.10. Local and Intercontinental Agreements
10.11. Intercontinental and Intracontinental Agreements
- USE CASE STUDY
11.1. Overview of Quantum Computing
11.2. Applications of Quantum Computing Across Various Industries
11.3. Upcoming Trends in Quantum Computing
11.4. Future Perspectives
- PORTER’S FIVE FORCES ANALYSIS
12.1. Methodology and Assumptions
12.2. Key Parameters
12.2.1. Threats of New Entrants
12.2.2. Bargaining Power of Buyers
12.2.3. Bargaining Power of Suppliers
12.2.4. Threats of Substitute Products
12.2.5. Rivalry among Existing Competitors
- BLUE OCEAN STRATEGY: A STRATEGIC GUIDE FOR START-UPS TO ENTER INTO HIGHLY COMPETITIVE MARKET
13.1. Overview of Blue Ocean Strategy
- MARKET SIZING AND OPPORTUNITY ANALYSIS
14.1. Forecast Methodology and Key Assumptions
14.2. Quantum Computing in Drug Discovery Services Market, 2023-2035
- EXECUTIVE INSIGHTS
- APPENDIX 1: TABULATED DATA
- APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery.html
News article
Non-viral Transfection Reagents and Systems Market
Learn from experts: do you know about these emerging industry trends?
Bioavailability Enhancement Technologies
Liposomes Development: Service Providers Landscape
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415